Too Much Sleeping Pills Prove Fatal

New Studies show that taking too much sleeping pills or anti-anxiety drugs increases ones risk of death by 36 percent, according to researchers at Universite Laval, Canada.

Even after adopting a clean healthy lifestyle, without alcohol use, smoking, health condition and the level of physical activity, the effect of too much intake of sleeping pills is still deemed fatal according to studies.

The report was based on 12 years of recorded studies done on 14,000 Canadians from Statistics Canada’s National Population Health Survey being carried every two years between the years 1994 and 2007 led by Professor Dr. Genevieve Belleville, M.D.. The study included the lifestyle, health conditions and social demographics of each participants between the ages of 18 to 102.

These pills are documented to cause drowsiness, impair thinking, slow reaction time, and wreck havoc on coordination. These effects contribute significantly in one’s chances of meeting with an accident, especially among the elderly. Statement about the study added that: “They [Sleeping and anti-anxiety medications] may also have an inhibiting effect on the respiratory system, which could aggravate certain breathing problems during sleep. These medications are also central nervous system inhibitors that may affect judgment and thus increase the risk of suicide.”

Safety concerns are also linked to taking sleeping pills and anti-anxiety medications especially when they are taken mixed with alcohol or other painkillers. Carelessness like these can cause death. In 2008, an accidental intake of both sleeping and anti-anxiety pills led to the early death of Australian actor Heath Ledger. Originally it was reported a case of recreational drug abuse but autopsy report showed combination of Xanax, Valium, Restoril and other drugs commonly used for treating insomnia, anxiety, depression and pain are inside Ledger’s body.

Dr. Belleville warned the public, “These medications aren’t candy, and taking them is far from harmless. Given that cognitive behavioural therapies have shown good results in treating insomnia and anxiety, doctors should systematically discuss such therapies with their patients as an option.”

Pharmaceutical Stocks

LIFE
75.94
0.00
0.00%
PDLI
7.04
-0.03
-0.42%
Q
67.26
+0.97
+1.46%
UTHR
172.96
+5.44
+3.25%
PRXL
68.38
+0.78
+1.15%
WX
37.64
+0.36
+0.97%
TECH
99.04
+0.57
+0.58%
CRL
79.61
+0.6
+0.76%
ICLR
70.46
+0.85
+1.22%
ANAC
54.85
+2.08
+3.94%
QGEN
25.41
+0.6
+2.42%
PCYC
256.555
+0.185
+0.072%
ANIK
40.81
+0.95
+2.38%
AMRI
17.56
+0.14
+0.80%
SKBI
4.01
+0.03
+0.75%
LGND
72.95
+2.65
+3.77%
VPHM
49.96
0.00
0.00%
LIFE
75.94
0.00
0.00%
PDLI
7.04
-0.03
-0.42%
Q
67.26
+0.97
+1.46%
UTHR
172.96
+5.44
+3.25%
PRXL
68.38
+0.78
+1.15%
WX
37.64
+0.36
+0.97%
TECH
99.04
+0.57
+0.58%
CRL
79.61
+0.6
+0.76%
ICLR
70.46
+0.85
+1.22%
ANAC
54.85
+2.08
+3.94%
QGEN
25.41
+0.6
+2.42%
PCYC
256.555
+0.185
+0.072%
ANIK
40.81
+0.95
+2.38%
AMRI
17.56
+0.14
+0.80%
SKBI
4.01
+0.03
+0.75%
LGND
72.95
+2.65
+3.77%
VPHM
49.96
0.00
0.00%

© 2015 Drugs News All rights reserved.       Privacy Policy       Contact Us